论文部分内容阅读
目的:报道胰腺中段切除术的手术经验。方法:对2008年3月—2011年8月期间8例行胰腺中段切除术的病例资料进行回顾性分析。结果:肿瘤最大径(26.4±5.1)mm。手术时间(242.6±56.3)min,术中出血(205.5±82.4)mL,切除胰腺长度(44.5±8.3)mm,术后发生胰瘘1例(12.5%),胃瘫1例(12.5%),肺部感染1例(12.5%),术后平均住院日(18.3±6.1)d。术后病理提示实性假乳头状瘤2例,浆液性囊腺瘤1例,黏液性囊腺瘤2例,胰岛细胞瘤1例,无功能性胰岛细胞瘤2例。随访时间5个月至3年(平均23个月),患者目前均存活,对手术效果基本满意,未出现新发糖尿病病例。结论:对于胰颈部或体部的良性肿瘤,胰腺中段切除术是安全有效的手术方式,值得临床推广。
Objective: To report the surgical experience of mid-pancreatic resection. Methods: A retrospective analysis was performed on 8 cases of mid pancreas resection between March 2008 and August 2011. Results: The largest diameter of tumor was (26.4 ± 5.1) mm. The operative time (242.6 ± 56.3) min, intraoperative bleeding (205.5 ± 82.4) mL, length of resected pancreas (44.5 ± 8.3) mm, postoperative pancreatic fistula in 1 case (12.5%) and gastric paralysis in 1 case One case of pulmonary infection (12.5%) and an average postoperative hospital stay (18.3 ± 6.1) d. Postoperative pathology showed two cases of solid pseudopapillary tumor, one case of serous cystadenoma, two cases of mucinous cystadenoma, one case of islet cell tumor and two cases of non-functioning islet cell tumor. The follow-up time ranged from 5 months to 3 years (mean, 23 months). All patients were alive at present, and were basically satisfied with the surgical results. No new-onset diabetes cases were found. Conclusion: For the benign tumor of the pancreas or body, the middle pancreatectomy is a safe and effective surgical method, which is worthy of clinical promotion.